Literature DB >> 34081583

LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network.

Deshan Zhou, Shaoliang Peng, Dong-Qing Wei, Wu Zhong, Yutao Dou, Xiaolan Xie.   

Abstract

An outbreak of COVID-19 that began in late 2019 was caused by a novel coronavirus(SARS-CoV-2). It has become a global pandemic. As of June 9, 2020, it has infected nearly 7 million people and killed more than 400,000, but there is no specific drug. Therefore, there is an urgent need to find or develop more drugs to suppress the virus. Here, we propose a new nonlinear end-to-end model called LUNAR. It uses graph convolutional neural networks to automatically learn the neighborhood information of complex heterogeneous relational networks and combines the attention mechanism to reflect the importance of the sum of different types of neighborhood information to obtain the representation characteristics of each node. Finally, through the topology reconstruction process, the feature representations of drugs and targets are forcibly extracted to match the observed network as much as possible. Through this reconstruction process, we obtain the strength of the relationship between different nodes and predict drug candidates that may affect the treatment of COVID-19 based on the known targets of COVID-19. These selected candidate drugs can be used as a reference for experimental scientists and accelerate the speed of drug development. LUNAR can well integrate various topological structure information in heterogeneous networks, and skillfully combine attention mechanisms to reflect the importance of neighborhood information of different types of nodes, improving the interpretability of the model. The area under the curve(AUC) of the model is 0.949 and the accurate recall curve (AUPR) is 0.866 using 10-fold cross-validation. These two performance indexes show that the model has superior predictive performance. Besides, some of the drugs screened out by our model have appeared in some clinical studies to further illustrate the effectiveness of the model.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34081583      PMCID: PMC8769035          DOI: 10.1109/TCBB.2021.3085972

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.702


  26 in total

1.  Drug-target interaction prediction using ensemble learning and dimensionality reduction.

Authors:  Ali Ezzat; Min Wu; Xiao-Li Li; Chee-Keong Kwoh
Journal:  Methods       Date:  2017-05-24       Impact factor: 3.608

2.  Computational Drug Repositioning with Random Walk on a Heterogeneous Network.

Authors:  Huimin Luo; Jianxin Wang; Min Li; Junwei Luo; Peng Ni; Kaijie Zhao; Fang-Xiang Wu; Yi Pan
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-05-02       Impact factor: 3.710

Review 3.  From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Authors:  Lu Zhang; Jianjun Tan; Dan Han; Hao Zhu
Journal:  Drug Discov Today       Date:  2017-09-04       Impact factor: 7.851

4.  Prediction of mRNA subcellular localization using deep recurrent neural networks.

Authors:  Zichao Yan; Eric Lécuyer; Mathieu Blanchette
Journal:  Bioinformatics       Date:  2019-07-15       Impact factor: 6.937

5.  Comparative Toxicogenomics Database (CTD): update 2021.

Authors:  Allan Peter Davis; Cynthia J Grondin; Robin J Johnson; Daniela Sciaky; Jolene Wiegers; Thomas C Wiegers; Carolyn J Mattingly
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

6.  Human Protein Reference Database--2009 update.

Authors:  T S Keshava Prasad; Renu Goel; Kumaran Kandasamy; Shivakumar Keerthikumar; Sameer Kumar; Suresh Mathivanan; Deepthi Telikicherla; Rajesh Raju; Beema Shafreen; Abhilash Venugopal; Lavanya Balakrishnan; Arivusudar Marimuthu; Sutopa Banerjee; Devi S Somanathan; Aimy Sebastian; Sandhya Rani; Somak Ray; C J Harrys Kishore; Sashi Kanth; Mukhtar Ahmed; Manoj K Kashyap; Riaz Mohmood; Y L Ramachandra; V Krishna; B Abdul Rahiman; Sujatha Mohan; Prathibha Ranganathan; Subhashri Ramabadran; Raghothama Chaerkady; Akhilesh Pandey
Journal:  Nucleic Acids Res       Date:  2008-11-06       Impact factor: 16.971

7.  Supervised prediction of drug-target interactions using bipartite local models.

Authors:  Kevin Bleakley; Yoshihiro Yamanishi
Journal:  Bioinformatics       Date:  2009-07-15       Impact factor: 6.937

8.  Prediction of drug-target interaction networks from the integration of chemical and genomic spaces.

Authors:  Yoshihiro Yamanishi; Michihiro Araki; Alex Gutteridge; Wataru Honda; Minoru Kanehisa
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

Review 9.  A Comprehensive Survey on Graph Neural Networks.

Authors:  Zonghan Wu; Shirui Pan; Fengwen Chen; Guodong Long; Chengqi Zhang; Philip S Yu
Journal:  IEEE Trans Neural Netw Learn Syst       Date:  2021-01-04       Impact factor: 10.451

10.  Predicting drug-target interactions using restricted Boltzmann machines.

Authors:  Yuhao Wang; Jianyang Zeng
Journal:  Bioinformatics       Date:  2013-07-01       Impact factor: 6.937

View more
  1 in total

1.  COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale.

Authors:  Wenliang Zhang; Yan Zhang; Zhuochao Min; Jing Mo; Zhen Ju; Wen Guan; Binghui Zeng; Yang Liu; Jianliang Chen; Qianshen Zhang; Hanguang Li; Chunxia Zeng; Yanjie Wei; Godfrey Chi-Fung Chan
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.